Barbra A Richardson1, Grace John-Stewart2, Claire Atkinson3, Ruth Nduati4, Kristjana Ásbjörnsdóttir5, Michael Boeckh6, Julie Overbaugh7, Vincent Emery8, Jennifer A Slyker9. 1. Department of Biostatistics Department of Global Health Vaccine and Infectious Disease Division Public Health Sciences Division. 2. Department of Global Health Department of Epidemiology Division of Allergy and Infectious Diseases, Department of Medicine Department of Pediatrics, University of Washington. 3. Institute for Immunity and Transplantation, University College, London. 4. Department of Pediatrics and Child health, School of Medicine, University of Nairobi, Kenya. 5. Department of Epidemiology. 6. Division of Allergy and Infectious Diseases, Department of Medicine Vaccine and Infectious Disease Division Clinical Research Division. 7. Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. 8. Department of Microbial and Cellular Sciences, University of Surrey, United Kingdom. 9. Department of Global Health.
Abstract
BACKGROUND:Cytomegalovirus (CMV) is associated with morbidity and mortality in human immunodeficiency virus (HIV)-exposed infants. We assessed the effect of and relative contribution of breastfeeding to CMV acquisition among infants delivered by HIV-infected mothers. METHODS:Between 1993 and 1998 pregnant, HIV-infected women in Nairobi, Kenya, were randomly assigned to breastfeed or formula-feed their infants in an HIV transmission study. Women were allocated equally between treatment arms, and the study was not blinded. The primary endpoint of this nested study was time to infant CMV infection. RESULTS:CMV infection was assessed in 138 breastfed and 134 formula-fed infants. Baseline characteristics were similar between arms. Breastfed infants acquired CMV earlier than formula-fed infants (median age of acquisition, 4.26 vs 9.87 months; P < .001) and had a higher 1-year probability of CMV infection (0.89 vs 0.69; P < .001). Breastfeeding was associated with a 1.6-fold increased risk of infant CMV acquisition independent of infant HIV status (multivariable hazard ratio, 1.61; 95% confidence interval, 1.20-2.16; P = .002). Approximately one third of CMV infections occurred during the peripartum period, with 40% acquired through breastfeeding and the remainder acquired through modes other than breast milk. CONCLUSIONS: Preventing CMV acquisition may be a priority for HIV-exposed infants, but there is a narrow window of opportunity for intervention. Approaches that reduce maternal cervical and breast milk CMV reactivation may help delay infant infection.
RCT Entities:
BACKGROUND: Cytomegalovirus (CMV) is associated with morbidity and mortality in human immunodeficiency virus (HIV)-exposed infants. We assessed the effect of and relative contribution of breastfeeding to CMV acquisition among infants delivered by HIV-infected mothers. METHODS: Between 1993 and 1998 pregnant, HIV-infectedwomen in Nairobi, Kenya, were randomly assigned to breastfeed or formula-feed their infants in an HIV transmission study. Women were allocated equally between treatment arms, and the study was not blinded. The primary endpoint of this nested study was time to infantCMV infection. RESULTS:CMV infection was assessed in 138 breastfed and 134 formula-fed infants. Baseline characteristics were similar between arms. Breastfed infants acquired CMV earlier than formula-fed infants (median age of acquisition, 4.26 vs 9.87 months; P < .001) and had a higher 1-year probability of CMV infection (0.89 vs 0.69; P < .001). Breastfeeding was associated with a 1.6-fold increased risk of infant CMV acquisition independent of infantHIV status (multivariable hazard ratio, 1.61; 95% confidence interval, 1.20-2.16; P = .002). Approximately one third of CMV infections occurred during the peripartum period, with 40% acquired through breastfeeding and the remainder acquired through modes other than breast milk. CONCLUSIONS: Preventing CMV acquisition may be a priority for HIV-exposed infants, but there is a narrow window of opportunity for intervention. Approaches that reduce maternal cervical and breast milk CMV reactivation may help delay infantinfection.
Authors: Mohammed M Beyari; T A Hodgson; W Kondowe; E M Molyneux; C Scully; S R Porter; C G Teo Journal: J Med Virol Date: 2005-04 Impact factor: 2.327
Authors: A Kovacs; M Schluchter; K Easley; G Demmler; W Shearer; P La Russa; J Pitt; E Cooper; J Goldfarb; D Hodes; M Kattan; K McIntosh Journal: N Engl J Med Date: 1999-07-08 Impact factor: 91.245
Authors: Toni Frederick; James Homans; LaShonda Spencer; Francoise Kramer; Alice Stek; Eva Operskalski; Andrea Kovacs Journal: Clin Infect Dis Date: 2012-06-06 Impact factor: 9.079
Authors: D D Panteleeff; G John; R Nduati; D Mbori-Ngacha; B Richardson; J Kreiss; J Overbaugh Journal: J Clin Microbiol Date: 1999-02 Impact factor: 5.948
Authors: Jennifer A Slyker; Barbara L Lohman-Payne; Grace C John-Stewart; Elizabeth Maleche-Obimbo; Sandra Emery; Barbra Richardson; Tao Dong; Astrid Kn Iversen; Dorothy Mbori-Ngacha; Julie Overbaugh; Vincent C Emery; Sarah L Rowland-Jones Journal: AIDS Date: 2009-10-23 Impact factor: 4.177
Authors: U A Gompels; N Larke; M Sanz-Ramos; M Bates; K Musonda; D Manno; J Siame; M Monze; S Filteau Journal: Clin Infect Dis Date: 2012-02-01 Impact factor: 9.079
Authors: Jennifer A Slyker; Barbra Richardson; Michael H Chung; Claire Atkinson; Kristjana H Ásbjörnsdóttir; Dara A Lehman; Michael Boeckh; Vincent Emery; James Kiarie; Grace John-Stewart Journal: AIDS Res Hum Retroviruses Date: 2016-12-06 Impact factor: 2.205
Authors: Juanita Pang; Jennifer A Slyker; Richard A Goldstein; Judith Breuer; Sunando Roy; Josephine Bryant; Claire Atkinson; Juliana Cudini; Carey Farquhar; Paul Griffiths; James Kiarie; Sofia Morfopoulou; Alison C Roxby; Helena Tutil; Rachel Williams; Soren Gantt Journal: Elife Date: 2020-12-31 Impact factor: 8.140